Quick Answer
Disc Medicine, Inc. reported Operating Income of -$236.02 million for fiscal year 2025.
Disc Medicine, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$236.02M | -81.9% |
| 2024 | -$129.72M | -42.4% |
| 2023 | -$91.12M | -91.9% |
| 2022 | -$47.48M | -53.5% |
| 2021 | -$30.93M | +9.1% |
| 2020 | -$34.04M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$67.70M | -106.0% | -10.2% |
| June 30, 2025 | -$61.41M | -99.0% | -53.7% |
| March 31, 2025 | -$39.95M | -27.0% | -21.6% |
| September 30, 2024 | -$32.86M | -73.3% | -6.5% |
| June 30, 2024 | -$30.85M | -78.0% | +1.9% |
| March 31, 2024 | -$31.46M | -25.2% | -66.0% |
| September 30, 2023 | -$18.96M | -80.9% | -9.4% |
| June 30, 2023 | -$17.33M | -44.2% | +31.0% |
- Disc Medicine, Inc. showed a decrease of -81.9% in Operating Income compared to the prior fiscal year.
- Over the 2020–2025 period, Disc Medicine, Inc.’s operating income has declined by 593.4% (from -$34.04 million to -$236.02 million).
- The most recent figure is from Disc Medicine, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: